Build Your Comparison

Side-by-side financial analysis
HNGE logo
HNGE
OMCL logo
OMCL
TDOC logo
TDOC
JPM logo
JPM
AMWL logo
AMWL
Try popular comparisons:

Stock Comparison

HNGE vs OMCL vs TDOC vs JPM vs AMWL

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HNGE
Hinge Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$5.15B
5Y Perf.+68.2%
OMCL
Omnicell, Inc.

Medical - Healthcare Information Services

HealthcareNASDAQ • US
Market Cap$1.72B
5Y Perf.+24.6%
TDOC
Teladoc Health, Inc.

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$1.32B
5Y Perf.+6.1%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+21.5%
AMWL
American Well Corporation

Medical - Healthcare Information Services

HealthcareNYSE • US
Market Cap$152M
5Y Perf.+35.2%

HNGE vs OMCL vs TDOC vs JPM vs AMWL — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HNGE logoHNGE
OMCL logoOMCL
TDOC logoTDOC
JPM logoJPM
AMWL logoAMWL
IndustryMedical - Healthcare Information ServicesMedical - Healthcare Information ServicesMedical - Healthcare Information ServicesBanks - DiversifiedMedical - Healthcare Information Services
Market Cap$5.15B$1.72B$1.32B$896.00B$152M
Revenue (TTM)$646M$1.23B$2.51B$280.33B$182M
Net Income (TTM)$-510M$20M$-171M$57.05B$-88M
Gross Margin80.8%43.5%65.6%60.0%38.7%
Operating Margin-81.6%2.7%-7.6%25.9%-50.6%
Forward P/E26.0x19.5x14.4x
Total Debt$8M$204M$1.04B$942.38B$5M
Cash & Equiv.$208M$197M$781M$343.34B$182M

HNGE vs OMCL vs TDOC vs JPM vs AMWLLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HNGE
OMCL
TDOC
JPM
AMWL
StockMay 25Jun 26Return
Hinge Health, Inc. (HNGE)100168.2+68.2%
Omnicell, Inc. (OMCL)100124.6+24.6%
Teladoc Health, Inc. (TDOC)100106.1+6.1%
JPMorgan Chase & Co. (JPM)100121.5+21.5%
American Well Corpo… (AMWL)100135.2+35.2%

Price return only. Dividends and distributions are not included.

Quick Verdict: HNGE vs OMCL vs TDOC vs JPM vs AMWL

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM leads in 5 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Hinge Health, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
🥇JPM emerged as the overall leader. Track its performance:
HNGE
Hinge Health, Inc.
The Growth Leader

HNGE is the #2 pick in this set and the best alternative if growth and momentum is your priority.

  • 50.6% revenue growth vs AMWL's -2.0%
  • +86.6% vs TDOC's +2.4%
Best for: growth and momentum
OMCL
Omnicell, Inc.
The Quality Angle

OMCL plays a supporting role in this comparison — it may shine differently against other peers.

Best for: healthcare exposure
TDOC
Teladoc Health, Inc.
The Growth Play

TDOC is the clearest fit if your priority is growth exposure.

  • Rev growth -1.5%, EPS growth 80.6%, 3Y rev CAGR 1.7%
Best for: growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.94, yield 1.9%
  • 465.8% 10Y total return vs HNGE's 74.0%
  • Better valuation composite
  • 20.4% margin vs HNGE's -78.9%
Best for: income & stability and long-term compounding
AMWL
American Well Corporation
The Defensive Pick

AMWL is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 1.45, Low D/E 1.8%, current ratio 3.37x
  • Beta 1.45, current ratio 3.37x
Best for: sleep-well-at-night and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthHNGE logoHNGE50.6% revenue growth vs AMWL's -2.0%
ValueJPM logoJPMBetter valuation composite
Quality / MarginsJPM logoJPM20.4% margin vs HNGE's -78.9%
Stability / SafetyJPM logoJPMBeta 0.94 vs TDOC's 1.85
DividendsJPM logoJPM1.9% yield; 15-year raise streak; the other 4 pay no meaningful dividend
Momentum (1Y)HNGE logoHNGE+86.6% vs TDOC's +2.4%
Efficiency (ROA)JPM logoJPM1.3% ROA vs HNGE's -69.5%, ROIC 4.5% vs -268.2%

HNGE vs OMCL vs TDOC vs JPM vs AMWL — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HNGEHinge Health, Inc.
FY 2025
Reportable Segment
100.0%$588M
OMCLOmnicell, Inc.
FY 2025
Connected Devices, Software Licenses, And Other
47.7%$565M
Technical Services
21.9%$260M
Hardware And Software
21.9%$259M
Consumables
8.5%$100M
TDOCTeladoc Health, Inc.
FY 2025
Other
100.0%$438M
JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000
AMWLAmerican Well Corporation
FY 2025
Platform Subscription
53.1%$132M
Visits
37.8%$94M
Others
9.1%$23M

HNGE vs OMCL vs TDOC vs JPM vs AMWL — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGAMWL

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 3 of 6 comparable metrics.

JPM is the larger business by revenue, generating $280.3B annually — 1536.1x AMWL's $182M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to HNGE's -78.9%. On growth, HNGE holds the edge at +47.2% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHNGE logoHNGEHinge Health, Inc.OMCL logoOMCLOmnicell, Inc.TDOC logoTDOCTeladoc Health, I…JPM logoJPMJPMorgan Chase & …AMWL logoAMWLAmerican Well Cor…
RevenueTrailing 12 months$646M$1.2B$2.5B$280.3B$182M
EBITDAEarnings before interest/tax-$524M$111M$42M$81.4B-$59M
Net IncomeAfter-tax profit-$510M$20M-$171M$57.0B-$88M
Free Cash FlowCash after capex$206M$112M$251M$100.9B-$42M
Gross MarginGross profit ÷ Revenue+80.8%+43.5%+65.6%+60.0%+38.7%
Operating MarginEBIT ÷ Revenue-81.6%+2.7%-7.6%+25.9%-50.6%
Net MarginNet income ÷ Revenue-78.9%+1.7%-6.8%+20.4%-48.2%
FCF MarginFCF ÷ Revenue+31.9%+9.1%+10.0%+36.0%-22.9%
Rev. Growth (YoY)Latest quarter vs prior year+47.2%+14.9%-2.5%-100.0%
EPS Growth (YoY)Latest quarter vs prior year-73.5%+2.7%+32.1%+16.0%+44.5%
JPM leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

TDOC leads this category, winning 3 of 6 comparable metrics.

At 16.0x trailing earnings, JPM trades at a 98% valuation discount to OMCL's 854.0x P/E. On an enterprise value basis, TDOC's 15.8x EV/EBITDA is more attractive than OMCL's 20.6x.

MetricHNGE logoHNGEHinge Health, Inc.OMCL logoOMCLOmnicell, Inc.TDOC logoTDOCTeladoc Health, I…JPM logoJPMJPMorgan Chase & …AMWL logoAMWLAmerican Well Cor…
Market CapShares × price$5.1B$1.7B$1.3B$896.0B$152M
Enterprise ValueMkt cap + debt − cash$4.9B$1.7B$1.6B$1.50T-$26M
Trailing P/EPrice ÷ TTM EPS-12.59x853.95x-6.44x16.00x-1.53x
Forward P/EPrice ÷ next-FY EPS est.25.96x19.53x14.40x
PEG RatioP/E ÷ EPS growth rate0.90x
EV / EBITDAEnterprise value multiple20.59x15.81x18.36x
Price / SalesMarket cap ÷ Revenue8.75x1.45x0.52x3.20x0.61x
Price / BookPrice ÷ Book value/share14.10x1.42x0.93x2.47x0.59x
Price / FCFMarket cap ÷ FCF30.14x19.80x4.64x8.88x
TDOC leads this category, winning 3 of 6 comparable metrics.

Profitability & Efficiency

JPM leads this category, winning 4 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-139 for HNGE. AMWL carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), OMCL scores 7/9 vs JPM's 5/9, reflecting strong financial health.

MetricHNGE logoHNGEHinge Health, Inc.OMCL logoOMCLOmnicell, Inc.TDOC logoTDOCTeladoc Health, I…JPM logoJPMJPMorgan Chase & …AMWL logoAMWLAmerican Well Cor…
ROE (TTM)Return on equity-138.7%+1.6%-12.4%+15.9%-33.5%
ROA (TTM)Return on assets-69.5%+1.0%-5.9%+1.3%-25.1%
ROICReturn on invested capital-2.7%+0.3%-11.5%+4.5%-95.1%
ROCEReturn on capital employed-135.5%+0.3%-10.0%+8.9%-36.6%
Piotroski ScoreFundamental quality 0–957656
Debt / EquityFinancial leverage0.02x0.17x0.75x2.60x0.02x
Net DebtTotal debt minus cash-$200M$8M$259M$599.0B-$178M
Cash & Equiv.Liquid assets$208M$197M$781M$343.3B$182M
Total DebtShort + long-term debt$8M$204M$1.0B$942.4B$5M
Interest CoverageEBIT ÷ Interest expense18.41x-8.76x0.74x-239.18x
JPM leads this category, winning 4 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $329 for AMWL. Over the past 12 months, HNGE leads with a +86.6% total return vs TDOC's +2.4%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs AMWL's -42.8% — a key indicator of consistent wealth creation.

MetricHNGE logoHNGEHinge Health, Inc.OMCL logoOMCLOmnicell, Inc.TDOC logoTDOCTeladoc Health, I…JPM logoJPMJPMorgan Chase & …AMWL logoAMWLAmerican Well Cor…
YTD ReturnYear-to-date+43.4%-16.2%+4.1%-0.5%+87.8%
1-Year ReturnPast 12 months+86.6%+26.4%+2.4%+21.8%+27.2%
3-Year ReturnCumulative with dividends+74.0%-47.7%-69.9%+138.2%-81.3%
5-Year ReturnCumulative with dividends+74.0%-73.5%-95.3%+118.2%-96.7%
10-Year ReturnCumulative with dividends+74.0%+12.4%-41.3%+465.8%-98.0%
CAGR (3Y)Annualised 3-year return+20.3%-19.4%-33.0%+33.6%-42.8%
JPM leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — HNGE and JPM each lead in 1 of 2 comparable metrics.

JPM is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than TDOC's 1.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HNGE currently trades 97.7% from its 52-week high vs OMCL's 68.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricHNGE logoHNGEHinge Health, Inc.OMCL logoOMCLOmnicell, Inc.TDOC logoTDOCTeladoc Health, I…JPM logoJPMJPMorgan Chase & …AMWL logoAMWLAmerican Well Cor…
Beta (5Y)Sensitivity to S&P 5001.32x1.13x1.85x0.94x1.45x
52-Week HighHighest price in past year$66.90$55.00$9.77$337.25$9.96
52-Week LowLowest price in past year$30.08$26.85$4.40$262.71$3.71
% of 52W HighCurrent price vs 52-week peak+97.7%+68.8%+75.1%+95.1%+91.5%
RSI (14)Momentum oscillator 0–10073.334.258.559.163.1
Avg Volume (50D)Average daily shares traded1.3M536K4.5M7.0M79K
Evenly matched — HNGE and JPM each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Analyst consensus: HNGE as "Buy", OMCL as "Hold", TDOC as "Hold", JPM as "Buy", AMWL as "Hold". Consensus price targets imply 51.2% upside for OMCL (target: $57) vs -30.5% for AMWL (target: $6). JPM is the only dividend payer here at 1.86% yield — a key consideration for income-focused portfolios.

MetricHNGE logoHNGEHinge Health, Inc.OMCL logoOMCLOmnicell, Inc.TDOC logoTDOCTeladoc Health, I…JPM logoJPMJPMorgan Chase & …AMWL logoAMWLAmerican Well Cor…
Analyst RatingConsensus buy/hold/sellBuyHoldHoldBuyHold
Price TargetConsensus 12-month target$74.18$57.20$7.40$339.75$6.33
# AnalystsCovering analysts1419426115
Dividend YieldAnnual dividend ÷ price+1.9%
Dividend StreakConsecutive years of raises15
Dividend / ShareAnnual DPS$5.95
Buyback YieldShare repurchases ÷ mkt cap+1.3%+4.5%0.0%+3.9%+0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

JPM leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TDOC leads in 1 (Valuation Metrics). 1 tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 3 of 6 categories
Loading custom metrics...

HNGE vs OMCL vs TDOC vs JPM vs AMWL: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is HNGE or OMCL or TDOC or JPM or AMWL a better buy right now?

For growth investors, Hinge Health, Inc.

(HNGE) is the stronger pick with 50. 6% revenue growth year-over-year, versus -2. 0% for American Well Corporation (AMWL). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Hinge Health, Inc. (HNGE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HNGE or OMCL or TDOC or JPM or AMWL?

On trailing P/E, JPMorgan Chase & Co.

(JPM) is the cheapest at 16. 0x versus Omnicell, Inc. at 854. 0x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 4x.

03

Which is the better long-term investment — HNGE or OMCL or TDOC or JPM or AMWL?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -96. 7% for American Well Corporation (AMWL). Over 10 years, the gap is even starker: JPM returned +465. 8% versus AMWL's -98. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HNGE or OMCL or TDOC or JPM or AMWL?

By beta (market sensitivity over 5 years), JPMorgan Chase & Co.

(JPM) is the lower-risk stock at 0. 94β versus Teladoc Health, Inc. 's 1. 85β — meaning TDOC is approximately 97% more volatile than JPM relative to the S&P 500. On balance sheet safety, American Well Corporation (AMWL) carries a lower debt/equity ratio of 2% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

05

Which is growing faster — HNGE or OMCL or TDOC or JPM or AMWL?

By revenue growth (latest reported year), Hinge Health, Inc.

(HNGE) is pulling ahead at 50. 6% versus -2. 0% for American Well Corporation (AMWL). On earnings-per-share growth, the picture is similar: Teladoc Health, Inc. grew EPS 80. 6% year-over-year, compared to -33. 6% for Hinge Health, Inc.. Over a 3-year CAGR, TDOC leads at 1. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HNGE or OMCL or TDOC or JPM or AMWL?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -89. 9% for Hinge Health, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -92. 9% for HNGE. At the gross margin level — before operating expenses — HNGE leads at 79. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HNGE or OMCL or TDOC or JPM or AMWL more undervalued right now?

On forward earnings alone, JPMorgan Chase & Co.

(JPM) trades at 14. 4x forward P/E versus 26. 0x for Hinge Health, Inc. — 11. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMCL: 51. 2% to $57. 20.

08

Which pays a better dividend — HNGE or OMCL or TDOC or JPM or AMWL?

In this comparison, JPM (1.

9% yield) pays a dividend. HNGE, OMCL, TDOC, AMWL do not pay a meaningful dividend and should not be held primarily for income.

09

Is HNGE or OMCL or TDOC or JPM or AMWL better for a retirement portfolio?

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +465. 8%, TDOC: -41. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HNGE and OMCL and TDOC and JPM and AMWL?

These companies operate in different sectors (HNGE (Healthcare) and OMCL (Healthcare) and TDOC (Healthcare) and JPM (Financial Services) and AMWL (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: HNGE is a small-cap high-growth stock; OMCL is a small-cap quality compounder stock; TDOC is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; AMWL is a small-cap quality compounder stock. JPM pays a dividend while HNGE, OMCL, TDOC, AMWL do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.